7-phenylethylamino-4h-pyrimido[4,5-d][1,3]oxazin-2-one compounds as mutant idh1 and idh2 inhibitors

Un compus, cum este definit aici, sau o compoziţie farmaceutică conţinȃnd compusul, pentru utilizare în tratarea cancerului mutant IDH1sau IDH2 avȃnd structura: A compound, as defined herein, or pharmaceutical composition containing the compound, for use in treating IDH1 or IDH2 mutant cancer and ha...

Full description

Saved in:
Bibliographic Details
Main Authors HAHN Patric James, RANKOVIC Zoran, BURKHOLDER Timothy Paul, BAUER Renato Alejandro, BOULET Serge Louis, GILMOUR Raymond
Format Patent
LanguageEnglish
Romanian
Published 31.01.2021
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Un compus, cum este definit aici, sau o compoziţie farmaceutică conţinȃnd compusul, pentru utilizare în tratarea cancerului mutant IDH1sau IDH2 avȃnd structura: A compound, as defined herein, or pharmaceutical composition containing the compound, for use in treating IDH1 or IDH2 mutant cancer and having the structure:
Bibliography:Application Number: MDE20191188T